• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    NVIDIA To Rally Over 39%? Here Are 10 Top Analyst Forecasts For Thursday

    5/23/24 7:48:17 AM ET
    $ADI
    $AGS
    $CB
    $CYTK
    Semiconductors
    Technology
    Miscellaneous manufacturing industries
    Consumer Discretionary
    Get the next $ADI alert in real time by email

    Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

    • B of A Securities boosted the price target for NVIDIA Corporation (NASDAQ:NVDA) from $1,100 to $1,320. B of A Securities analyst Vivek Arya maintained a Buy rating. NVIDIA shares fell 0.5% to close at $949.50 on Wednesday. See how other analysts view this stock.
    • Telsey Advisory Group cut the price target for Foot Locker, Inc. (NYSE:FL) from $28 to $26. Telsey Advisory Group analyst Joseph Feldman maintained a Market Perform rating. Foot Locker shares fell 0.4% to close at $22.82 on Wednesday. See how other analysts view this stock.
    • Mizuho raised DuPont de Nemours, Inc. (NYSE:DD) price target from $83 to $100. Mizuho analyst John Roberts maintained a Buy rating. DuPont shares fell 1.2% to close at $78.55 on Wednesday. See how other analysts view this stock.
    • Needham slashed the price target for Cytokinetics, Incorporated (NASDAQ:CYTK) from $108 to $72. Needham analyst Serge Belanger maintained a Buy rating. Cytokinetics shares fell 1.5% to close at $59.23 on Wednesday. See how other analysts view this stock.
    • B of A Securities boosted Chubb Limited (NYSE:CB) price target from $244 to $266. B of A Securities analyst Joshua Shanker upgraded the stock from Underperform to Neutral. Chubb shares rose 0.9% to close at $267.44 on Wednesday. See how other analysts view this stock.
    • JP Morgan increased Hasbro, Inc. (NASDAQ:HAS) price target from $61 to $74. JP Morgan analyst Christopher Horvers upgraded the stock from Neutral to Overweight. Hasbro shares fell 3.4% to close at $60.33 on Wednesday. See how other analysts view this stock.
    • Keybanc raised the price target for Analog Devices, Inc. (NASDAQ:ADI) from $230 to $285. Keybanc analyst John Vinh  maintained an Overweight rating. Analog Devices shares rose 10.9% to close at $240.16 on Wednesday. See how other analysts view this stock.
    • Piper Sandler raised Synopsys, Inc. (NASDAQ:SNPS) price target from $665 to $672. Piper Sandler analyst Clarke Jeffries reiterated an Overweight rating. Synopsys shares rose 0.3% to close at $573.13 on Wednesday. See how other analysts view this stock.
    • Stifel increased PlayAGS, Inc. (NYSE:AGS) price target from $12 to $12.5. Stifel analyst Brad Boyer downgraded the stock from Buy to Hold. PlayAGS shares fell 0.2% to close at $11.58 on Wednesday. See how other analysts view this stock.
    • Needham cut Snowflake Inc. (NYSE:SNOW) price target from $240 to $210. Needham analyst Mike Cikos maintained a Buy rating. Snowflake shares rose 0.4% to close at $163.34 on Wednesday. See how other analysts view this stock.

    Check This Out: Investor Sentiment Falls Further After Fed Minutes, Dow Tumbles 200 Points

    Get the next $ADI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADI
    $AGS
    $CB
    $CYTK

    CompanyDatePrice TargetRatingAnalyst
    Analog Devices Inc.
    $ADI
    2/12/2026$375.00Equal Weight → Overweight
    Barclays
    Cytokinetics Incorporated
    $CYTK
    1/28/2026$87.00Overweight
    Barclays
    NVIDIA Corporation
    $NVDA
    1/15/2026$240.00Outperform
    RBC Capital Mkts
    Analog Devices Inc.
    $ADI
    1/15/2026$340.00Equal Weight → Overweight
    Wells Fargo
    Synopsys Inc.
    $SNPS
    1/13/2026$520.00Overweight → Neutral
    Piper Sandler
    Snowflake Inc.
    $SNOW
    1/12/2026$250.00Buy
    Goldman
    Snowflake Inc.
    $SNOW
    1/12/2026$250.00Overweight → Equal Weight
    Barclays
    Chubb Limited
    $CB
    1/8/2026$351.00Neutral → Buy
    Goldman
    More analyst ratings

    $ADI
    $AGS
    $CB
    $CYTK
    SEC Filings

    View All

    SEC Form 144 filed by Hasbro Inc.

    144 - HASBRO, INC. (0000046080) (Subject)

    2/12/26 4:09:46 PM ET
    $HAS
    Recreational Games/Products/Toys
    Consumer Discretionary

    Hasbro Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - HASBRO, INC. (0000046080) (Filer)

    2/10/26 6:35:40 AM ET
    $HAS
    Recreational Games/Products/Toys
    Consumer Discretionary

    DuPont de Nemours Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - DuPont de Nemours, Inc. (0001666700) (Filer)

    2/10/26 6:06:47 AM ET
    $DD
    Major Chemicals
    Industrials

    $ADI
    $AGS
    $CB
    $CYTK
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Painter Robert G bought $148,904 worth of shares (350 units at $425.44), increasing direct ownership by 18% to 2,291 units (SEC Form 4)

    4 - SYNOPSYS INC (0000883241) (Issuer)

    9/15/25 7:19:16 PM ET
    $SNPS
    Computer Software: Prepackaged Software
    Technology

    Director Corbat Michael bought $114,665 worth of shares (425 units at $269.80), increasing direct ownership by 21% to 2,450 units (SEC Form 4)

    4 - Chubb Ltd (0000896159) (Issuer)

    7/28/25 3:59:55 PM ET
    $CB
    Property-Casualty Insurers
    Finance

    President & COO Keogh John W bought $2,874,135 worth of shares (9,810 units at $292.99) and sold $2,869,447 worth of shares (9,794 units at $292.99), increasing direct ownership by 4% to 247,538 units (SEC Form 4)

    4 - Chubb Ltd (0000896159) (Issuer)

    6/10/25 6:31:10 PM ET
    $CB
    Property-Casualty Insurers
    Finance

    $ADI
    $AGS
    $CB
    $CYTK
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Analog Devices upgraded by Barclays with a new price target

    Barclays upgraded Analog Devices from Equal Weight to Overweight and set a new price target of $375.00

    2/12/26 8:03:47 AM ET
    $ADI
    Semiconductors
    Technology

    Barclays resumed coverage on Cytokinetics with a new price target

    Barclays resumed coverage of Cytokinetics with a rating of Overweight and set a new price target of $87.00

    1/28/26 7:16:37 AM ET
    $CYTK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    RBC Capital Mkts initiated coverage on NVIDIA with a new price target

    RBC Capital Mkts initiated coverage of NVIDIA with a rating of Outperform and set a new price target of $240.00

    1/15/26 8:38:56 AM ET
    $NVDA
    Semiconductors
    Technology

    $ADI
    $AGS
    $CB
    $CYTK
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Cytokinetics to Announce Fourth Quarter Results on February 24, 2026

    SOUTH SAN FRANCISCO, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (NASDAQ:CYTK) today announced that it is scheduled to report fourth quarter results on February 24, 2026 at 4:00 PM Eastern Time. Following the announcement, Cytokinetics' senior management will host a conference call at 4:30 PM Eastern Time to discuss financial results and provide business updates. The conference call will be simultaneously webcast and can be accessed from the Investors & Media section of Cytokinetics' website at www.cytokinetics.com or directly at the following link: Cytokinetics Q4 2025 Earnings Conference Call. An archived replay of the webcast will be available via Cytokinetics'

    2/12/26 4:00:00 PM ET
    $CYTK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    U.S. Figure Skating Elevates Athlete Development and Fan Engagement with Snowflake Intelligence

    The collaboration brings Snowflake Intelligence, an enterprise intelligence agent, to the heart of U.S. Figure Skating, transforming data into faster decisions, smarter strategy and stronger foundation for the sport Snowflake Intelligence will combine athlete performance, fan engagement, and business operations data into a single, reliable source of insight Leaders and coaches will gain contextual visibility into performance trends, using natural language to uncover deeper insights and inform decisions on and off the ice The collaboration builds on Snowflake's commitment as the Official Data Collaboration Provider for Team USA and the LA28 Games to deliver the most data-driven Game

    2/12/26 3:00:00 PM ET
    $SNOW
    Computer Software: Prepackaged Software
    Technology

    DuPont Named Finalist in 2026 Edison Awards for FilmTec™ Fortilife™ XC160UHP Membrane for Wastewater Treatment and Reuse

    WILMINGTON, Del., Feb. 12, 2026 /PRNewswire/ -- DuPont (NYSE:DD) is proud to announce that its FilmTec™ Fortilife™ XC160UHP reverse osmosis elements for industrial wastewater treatment and reuse, has been honored as a finalist in the 2026 Edison Awards in the Water, Food and Agriculture category.  The FilmTec™ Fortilife™ XC160UHP element is a reverse osmosis element designed to concentrate wastewater streams, providing a more efficient and sustainable approach to water reuse and wastewater treatment. With the ability to operate under ultra-high-pressure conditions, FilmTec™ Fo

    2/12/26 9:00:00 AM ET
    $DD
    Major Chemicals
    Industrials

    $ADI
    $AGS
    $CB
    $CYTK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Executive Vice President* Boroughs Timothy Alan exercised 27,817 shares at a strike of $138.25 and sold $9,234,688 worth of shares (27,817 units at $331.98) (SEC Form 4)

    4 - Chubb Ltd (0000896159) (Issuer)

    2/10/26 4:05:14 PM ET
    $CB
    Property-Casualty Insurers
    Finance

    Chairman & CEO Greenberg Evan G sold $4,991,867 worth of shares (15,060 units at $331.47), decreasing direct ownership by 3% to 511,576 units (SEC Form 4)

    4 - Chubb Ltd (0000896159) (Issuer)

    2/9/26 4:05:04 PM ET
    $CB
    Property-Casualty Insurers
    Finance

    Director Speiser Michael L sold $8,383,608 worth of shares (50,741 units at $165.22), decreasing direct ownership by 2% to 23,718 units (SEC Form 4)

    4 - Snowflake Inc. (0001640147) (Issuer)

    2/6/26 7:34:20 PM ET
    $SNOW
    Computer Software: Prepackaged Software
    Technology

    $ADI
    $AGS
    $CB
    $CYTK
    Financials

    Live finance-specific insights

    View All

    Cytokinetics to Announce Fourth Quarter Results on February 24, 2026

    SOUTH SAN FRANCISCO, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (NASDAQ:CYTK) today announced that it is scheduled to report fourth quarter results on February 24, 2026 at 4:00 PM Eastern Time. Following the announcement, Cytokinetics' senior management will host a conference call at 4:30 PM Eastern Time to discuss financial results and provide business updates. The conference call will be simultaneously webcast and can be accessed from the Investors & Media section of Cytokinetics' website at www.cytokinetics.com or directly at the following link: Cytokinetics Q4 2025 Earnings Conference Call. An archived replay of the webcast will be available via Cytokinetics'

    2/12/26 4:00:00 PM ET
    $CYTK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Hasbro Reports Fourth Quarter and Full Year 2025 Financial Results

    Playing to Win Drives Revenue, Profit and Earnings Growth for the Full Year Company Issues 2026 Guidance and Declares Dividend Announces $1 Billion Share Repurchase Program Hasbro, Inc. (NASDAQ:HAS), a leading games, IP, and toy company, today reported financial results for the fourth quarter and full year 2025. "I am proud of the results our team delivered in 2025 and the success of our Playing to Win strategy," said Chris Cocks, Chief Executive Officer of Hasbro. "We returned the company to growth, engaged one billion fans, secured new partnerships, and made progress in our evolution into a digital-first play and IP company. We expect that momentum to carry into 2026." "2025 ref

    2/10/26 6:30:00 AM ET
    $HAS
    Recreational Games/Products/Toys
    Consumer Discretionary

    DuPont Reports Fourth Quarter and Full Year 2025 Results

    Exceeds Fourth Quarter and Full Year 2025 Guidance Initiates First Quarter and Full Year 2026 Guidance  Fourth Quarter 2025 Highlights Net Sales of $1.7 billion were flat; organic sales decreased 1% versus year-ago period including a $30 million, or 2%, headwind from the third quarter timing shiftGAAP Loss from continuing operations of $(108) million; operating EBITDA of $409 millionGAAP EPS from continuing operations of $(0.27); adjusted EPS of $0.46Cash provided by operating activities from continuing operations of $87 million, including $228 million of separation-related transaction cost and other payments; transaction-adjusted free cash flow of $228 millionFull Year 2025 Highlights Net S

    2/10/26 6:00:00 AM ET
    $DD
    Major Chemicals
    Industrials

    $ADI
    $AGS
    $CB
    $CYTK
    Leadership Updates

    Live Leadership Updates

    View All

    Edgewater Wireless Issues 2026 Corporate Update

    "Wi-Fi8 Before Wi-Fi8" – Accelerating Wi-Fi8-ready Spectrum Slicing™ Silicon with Silicon Catalyst Ecosystem, Arm, Synopsys and FABrIC Support Edgewater Wireless Systems Inc. (TSXV:YFI) (OTC:KPIFF), the industry pioneer of AI-powered Wi-Fi Spectrum Slicing™ silicon solutions and IP for residential, enterprise and Industrial IoT markets, today issued a corporate update outlining the Company's material progress over the past 12 months and its 2026 execution roadmap toward Wi-Fi8-ready silicon deliverables and strategic commercialization. Over the last year, Edgewater has evolved from an innovation-led Wi-Fi disruptor into a globally recognized reliability and low-latency thought leader, a

    2/5/26 7:01:00 AM ET
    $ARM
    $SNPS
    Semiconductors
    Technology
    Computer Software: Prepackaged Software

    Cytokinetics and Olympic Gold Medalist Sydney McLaughlin-Levrone Team Up to Raise Awareness of the Whole-Person Impact of Hypertrophic Cardiomyopathy (HCM)

    "On Track with HCM" Features Practical Insights for Managing Everyday Life with the Disease, Inspired by the Experience with HCM of McLaughlin-Levrone's Father, Willie McLaughlin SOUTH SAN FRANCISCO, Calif., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (NASDAQ:CYTK) today announced the launch of "On Track with HCM," demonstrating the company's long-standing commitment to the HCM community. The campaign features four-time Olympic gold medalist Sydney McLaughlin-Levrone, and her father, three-time all-American track star, Willie McLaughlin, who suffered from the non-obstructive form of hypertrophic cardiomyopathy (HCM) for more than two decades before receiving a heart trans

    1/27/26 8:00:00 AM ET
    $CYTK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Analog Devices Appoints Yoky Matsuoka to its Board of Directors

    WILMINGTON, Mass., Jan. 23, 2026 /PRNewswire/ -- Analog Devices, Inc. (NASDAQ:ADI) today announced the appointment of Dr. Yoky Matsuoka to its Board of Directors as an independent director and member of the Board's Corporate Development Committee effective January 20, 2026. Dr. Matsuoka's appointment expands the Board to 11 members. Dr. Matsuoka serves as an executive officer of Panasonic Holdings, a global leader in the development of innovative technologies and solutions for wide-ranging applications across industries. In this role, she is responsible for global innovation a

    1/23/26 7:03:00 AM ET
    $ADI
    Semiconductors
    Technology

    $ADI
    $AGS
    $CB
    $CYTK
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Cytokinetics Incorporated

    SC 13G - CYTOKINETICS INC (0001061983) (Subject)

    11/14/24 1:28:31 PM ET
    $CYTK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Chubb Limited

    SC 13G/A - Chubb Ltd (0000896159) (Subject)

    11/14/24 1:22:34 PM ET
    $CB
    Property-Casualty Insurers
    Finance

    Amendment: SEC Form SC 13G/A filed by PlayAGS Inc.

    SC 13G/A - PlayAGS, Inc. (0001593548) (Subject)

    11/14/24 12:14:41 PM ET
    $AGS
    Miscellaneous manufacturing industries
    Consumer Discretionary